Prosecution Insights
Last updated: May 29, 2026

Examiner: LOPEZ, SEVERO ANTON P

Tech Center 3700 • Art Units: 3791 3796

This examiner grants 33% of resolved cases

Performance Statistics

33.1%
Allow Rate
-36.9% vs TC avg
240
Total Applications
+36.1%
Interview Lift
1350
Avg Prosecution Days
Based on 154 resolved cases, 2023–2026

Rejection Statute Breakdown

5.7%
§101 Eligibility
9.6%
§102 Novelty
74.0%
§103 Obviousness
8.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17885703 WEARABLE ELECTRONIC DEVICE AND METHOD FOR PROVIDING INFORMATION OF BRUSHING TEETH IN WEARABLE ELECTRONIC DEVICE Final Rejection Samsung Electronics Co., Ltd.
18393929 FEATURE-AMOUNT GENERATION DEVICE, GAIT MEASUREMENT SYSTEM, FEATURE-AMOUNT GENERATION METHOD, AND RECORDING MEDIUM Non-Final OA NEC Corporation
17981063 HIP KNEE RANGE OF MOTION MEASUREMENT DEVICE Non-Final OA Imam Abdulrahman Bin Faisal University
16949581 METHOD FOR RECOGNIZING A MOTION PATTERN OF A LIMB Non-Final OA The Chinese University of Hong Kong
18627989 SYSTEM AND METHODS FOR NON-RESPONSIVE SENSOR DETECTION Non-Final OA Dexcom, Inc.
18681774 ESTIMATING OXYGEN SATURATION USING GREEN OPTICAL LIGHT AS A FILTER Non-Final OA Google LLC
18638809 Systems and Methods for Dynamic Neurophysiological Stimulation Non-Final OA Cadwell Laboratories, Inc.
17258135 GRIP PROFILE SENSING AND ASSESSMENT Non-Final OA The Regents of the University of Michigan
18121704 Joint Evaluation Final Rejection Howmedica Osteonics Corp.
18184218 HEMOLYSIS-REDUCTION ACCESSORIES FOR DIRECT BLOOD DRAW Final Rejection CAREFUSION 303, INC.
18237163 Blood Culture Sample Collection System Final Rejection Becton, Dickinson and Company
18236150 A Blood Collection Device with Improved Blood Draw Time Final Rejection Becton, Dickinson and Company
18320254 Offset Fluid Path for Blood Draw Device Final Rejection Becton, Dickinson and Company
18118449 Small Sample Collection and Dispensing Device for Use with Luer Lock Access Device and Point-of-Care Diagnostics Non-Final OA Becton, Dickinson and Company
18117748 Blood Collection Device for Small Volume Sample Acquisition Through Peripheral Intravenous Catheters Final Rejection Becton, Dickinson and Company
18117043 Integrated Catheter System and Methods for Collection of a Blood Culture Sample Non-Final OA Becton, Dickinson and Company
17852553 Blood Collection Device and Related Systems and Methods Non-Final OA Becton, Dickinson and Company
17537576 DEVICE FOR TRAPPING AN INITIAL FLOW OF BLOOD Non-Final OA BECTON DICKINSON AND COMPANY
17867684 GUIDE WIRE Non-Final OA Asahi Intecc Co., Ltd.
17600186 IN VIVO IMMUNOASSAY SYSTEM Non-Final OA Given Imaging LTD
16660698 TESTING COGNITIVE ABILITY OF USER TO SELF-TREAT FROM MEDICAL EVENT Non-Final OA Roche Diabetes Care, Inc.
18256454 TORQUER FOR AN ELONGATED MEDICAL DEVICE Non-Final OA Corindus, Inc.
17639510 QUANTIFICATION OF SYMMETRY AND REPEATABILITY IN LIMB MOTION FOR TREATMENT OF ABNORMAL MOTION PATTERNS Final Rejection University of Miami
18597546 SYSTEMS FOR REDUCING FRICTION IN ENDOVASCULAR DEVICES Non-Final OA Rapid Medical Ltd.
17526918 Blood Collection Device Final Rejection Thomas J. Shaw
18517674 METHOD FOR PREDICTING AEROBIC THRESHOLD AND ANAEROBIC THRESHOLD AND ESTABLISHING THE OPTIMAL AEROBIC TRAINING ZONE Non-Final OA SAMSUNG ELETRÔNICA DA AMAZÔNIA LTDA.
18196828 METHOD AND SYSTEM FOR ESTIMATING DISTANCE BETWEEN A FIBER END AND A TARGET Final Rejection Lumenis Ltd.
18702261 OCULAR SUCTION DEVICE Non-Final OA HOPITAL FONDATION ADOLPHE DE ROTHSCHILD
16986251 OPTICAL DIAGNOSTIC SENSOR SYSTEMS AND METHODS Non-Final OA Maxim Integrated Products, Inc.
18694421 ANALYTE DETECTION DEVICE WITH BATTERY AND SHELL INTEGRATED Non-Final OA MEDTRUM TECHNOLOGIES INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month